Main Content

The Tom Sherak MS Hope Foundation is a game-changing, action-oriented, nonprofit organization that responds, with immediacy, to the needs of people with multiple sclerosis by supporting innovative, person to-person programs and services, and funding cutting edge research.

The Tom Sherak MS Hope Foundation partners with leading MS research institutions such as UCLA, UCSF, and others to develop new treatments to slow down the progression of MS; determine the causes and triggers of MS; and ultimately to find a cure for MS. We are proud to have provided grants to world-renowned MS neurologists such as Dr. Rhonda Voskuhl and Dr. Stephen Hauser for their ground-breaking research. We also support the needs of those living with MS in our local area by funding requests from individuals living with MS for equipment and scholarships to The Marilyn Hilton MS Achievement Center at UCLA.

We couldn’t do this without your generosity and we are proud to say that 93.5% of every dollar raised goes directly to funding these and other action-oriented, cutting edge measures.

Thank you for caring and giving hope to so many.

Recent News

Searching for Miracles this #GivingTuesday

January 28, 2019 marks the five–year anniversary of Tom Sherak’s death. Tom Sherak was my dad, my champion, my hero. He loved me unconditionally and with all of his heart and soul. He did everything he possibly could to keep me safe and healthy. You see, I was diagnosed with Multiple Sclerosis (MS) 31 years […]

Researchers Find Potential Path Using Gene Expression to Repair Nerves damaged by MS

The Voskuhl Laboratory analyzed astrocytes, a type of brain cell, in different regions of the brain and spinal cord that are involved in walking, vision and cognition. After comparing gene expression changes among regions that correspond to different disabilities, they observed that these gene expression changes differed between regions.

Using Estrogen as a Mechanism in Multiple Sclerosis

Oestrogen receptor beta (ERβ) ligands have been identified as potential candidates in achieving neuroprotection and preventing neuronal degeneration in MS. Targeting ERβ signaling pathways in CD11c+ cells is a novel strategy for regulating the innate immune system of MS.

MS Hope Foundation